Patent · US Active

Hetero-dimeric multi-specific antibody format

US11236150B2 · kind B2 · utility

1Cited by

0References

17Claims

0Family size

Assignee

Numab Therapeutics AG · CH

Inventors

Sebastian Meyer · Bielefeld, DE
David Urech · Jona, CH

Key dates

Filing date	Jun 15, 2016
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Apr 8, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/626
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to a novel hetero-dimeric multi-specific format of multiple antibody variable domains comprising a core of two split variable domain pairs wherein both variable light domains and the two cognate variable heavy domains are positioned in tandem on two separate protein chains, respectively.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.